Several studies have reported increased expression of L1CAM in EVs in various central nervous system disorders including Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (Ngolab et al., 2017; Shi et al., 2014). Here, L1CAM is linked to Parkinson disease.